Question 1

What is the catalog number for Human RASEF Knockout A549 cell line?

Accepted Answer

The catalog number for Human RASEF Knockout A549 cell line is A549KO-17569.

Question 2

What sizes are available for Human RASEF Knockout A549 cell line?

Accepted Answer

Human RASEF Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human RASEF Knockout A549 cell line in stock?

Accepted Answer

Human RASEF Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human RASEF Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with RASEF gene knockout, sequence confirmed.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 7

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Human RASEF Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

BEND7 3'UTR Luciferase Stable Cell Line

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)